CSL to invest $1.5B in US for plasma therapy manufacturing
CSL is making a $1.5 billion move in US biopharma manufacturing. The investment will expand its...
Read more
Pharma
How domestic pharma manufacturing became central to America’s agenda
As the US faces growing tension with China and persistent drug shortages, reshoring pharmaceutical manufacturing has...
Read more
Merck doubles down on US soil with $70B investment strategy
With thousands of jobs on the way and facilities breaking ground across New Jersey, Delaware and...
Read more
GSK outlines $30 billion US push in R&D and manufacturing
GSK’s $30 billion investment plan marks a major step in reshaping how the biopharma industry connects...
Read more
AstraZeneca commits $4.5B to build US drug hub in Virginia
AstraZeneca is putting $4.5 billion behind a future-focused strategy in Albemarle County, Virginia.
Read more